Compounds made from isocyclic amides, quinassa inhibitor rip1； pharmaceutical ingredients including these compounds； and compounds used to treat diseases such as inflammation, autoimmunity, nerves, lungs, etc.". PCT
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
RAMANJULU JOSHI M.,BANDYOPADHYAY DEEPAK,EIDAM PATRICK M.,GOUCH PETER J.,HARRIS PHILIP ANTHONY,JEONG JAE U.,KANG JIANXING,KING BRYAN WAYNE,LAKDAWALA SHAH AMI,MARQUIS JR. ROBERT W.,LEISTER LARA KATHRYN
申请号：
CL2015002279
公开号：
CL2015002279A1
申请日:
2015.08.14
申请国别(地区):
CL
年份:
2016
代理人:
摘要：
Heterocyclic amide Compounds, inhibitors of kinase coposicion Ripi； Pharmaceutical； a method for treating a disease or Disorder； use for treating a disease or Disorder seleconado ulcerative colitis, psoriasis, pigmentary nephritis, rheumatoid arthritis, gout, pancreatitis, I Patitis autoimmune, among others.LA SOLICITUD SE REFIERE A COMPUESTOS DERIVADOS DE AMIDAS HETEROCICLICAS, INHIBIDORES DE QUINASA RIP1, A UNA COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE Y A SU USO EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS, AUTOINMUNES, NEUROLÓGICAS, PULMONARES, ENTRE OTRAS.
